stockrow
Friday 6 November 2026
Export TEM’s income statement to Excel — free account
Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Revenue
- +23.1%
- EPS
- +82.2%
- Free cash flow
- +95.7%
- Total debt
- +8.44%
Quarter to September 2026, against a year earlier
76.26
5.83
+8.28%
Follow TEM
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
8.09 | 5.93 | 7.28 | 9.84 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(279.72) | (110.39) | (1,385.06) | 1,611.26 | |
P/B ratio |
20.94 | 19.43 | 23.43 | 29.67 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
8.47 | 6.37 | 7.66 | 10.31 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(49.41) | (46.75) | (46.19) | (143.60) | |
EV/FCF |
(43.92) | (39.52) | (40.18) | (103.32) | |
Quick Ratio |
2.86 | 2.98 | 3.01 | 2.33 | |
Current Ratio |
3.13 | 3.31 | 3.30 | 2.61 | |
Net Debt/EBITDA |
(14.71) | (10.42) | (11.31) | (24.87) | |
Debt/Assets |
54.49% | 57.76% | 57.51% | 55.10% | |
Debt/Equity |
2.52 | 2.96 | 3.06 | 2.70 | |
Asset Turnover |
0.79 | 0.74 | 0.72 | 0.64 | |
Operating CF/Net income |
0.68 | 0.58 | (1.33) | (0.62) | |
Capex/Depreciation |
(0.22) | (0.36) | (0.40) | (0.52) | |
Interest Coverage |
(4.02) | (5.91) | (7.38) | (8.49) | |
Research and Development Expense of Revenue |
24.68% | 27.05% | 25.25% | 22.28% | |
Selling, General and Administrative Expense of Revenue |
56.78% | 61.07% | 59.05% | 56.34% | |
Intangible Assets out of Total Assets |
0.36 | 0.38 | 0.33 | 0.32 | |
Share Based Compensation of Revenue |
12.35% | 15.14% | 14.15% | 11.68% | |
Graham Net Nets |
(0.06) | (0.08) | (0.06) | (0.05) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(2.39%) | (3.78%) | (2.47%) | (1.28%) | |
Free Cash Flow Yield |
(2.38%) | (2.72%) | (2.62%) | (1.01%) | |
Revenue per Share |
2.11 | 1.95 | 2.13 | 2.27 | |
Operating CF per Share |
(0.21) | (0.41) | (0.04) | 0.05 | |
Capex per Share |
(0.04) | (0.06) | (0.06) | (0.08) | |
Free Cash Flow per Share |
(0.25) | (0.47) | (0.10) | (0.03) | |
Cash per Share |
4.33 | 3.57 | 4.54 | 3.52 | |
Shareholders Equity per Share |
2.82 | 2.33 | 2.47 | 2.76 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.82 | 2.33 | 2.47 | 2.76 | |
Free Cash Flow |
(43.12) | (83.34) | (18.62) | (5.54) | |
Working Capital |
794.79 | 735.99 | 899.37 | 700.47 | |
Capital Expenditures |
(6.34) | (10.07) | (11.09) | (14.76) | |
Net Current Asset Value |
(616.34) | (664.74) | (630.11) | (814.32) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.04 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
232.99 | 285.61 | 313.60 | 332.19 | |
Average Payables |
67.90 | 64.88 | 76.57 | 65.03 | |
Average Inventory |
45.06 | 51.16 | 50.56 | 54.37 | |
Average Assets |
1,600.48 | 1,839.11 | 1,995.64 | 2,366.51 | |
Average Common Equity |
273.83 | 371.30 | 377.25 | 504.11 |
Columns are period end dates · fundamentals updated 5 Nov 2026